About Us 关于我们

Taikangnuo Biotech is a digital biomedical company incubated by the Tech300 Angel Fund of City University of Hong Kong. The team is mainly composed of doctors and postdoctoral fellows from the Department of Neuroscience of City University of Hong Kong. We have developed AnimismTM, a multimodal AI large model cloud platform, focusing on the recognition and analysis of behavioral representations of brain diseases. The company has more than ten automated behavioral analysis modules, covering multiple fields such as experimental animals, pets, livestock, and patients, serving global customers, and cooperating with many medical institutions.

泰康诺生物科技有限公司(TKN Biotech)2023年3月在香港成立,由香港城市大学HK Tech 300基金孵化,核心团队来自城大神经科学系博士与博士后。公司专注AI+行为学,打造NeuCap™AI驱动癫痫院外智能监护的解决方案,利用多模态大模型实时解析实验动物与人类神经行为,覆盖癫痫、帕金森、弱视等模型,为药企、医院、科研机构提供高效、低成本数据服务,已获NVIDIA初创加速计划与百万级港元天使轮支持,并获中国国际大学生创新大赛金奖。

Experienced AI
& Bio Experts

100% Customer
Satisfaction Rate

Beyond Expert
Performance

Four Pillars of
AI Platform

At TKN Biotech, our approach to AI digital medicine is built upon four fundamental pillars: Expertise, Technology, Versatility, and Colloboration. Our flagship platform, Animism™, leverages advanced AI models and neuroscience expertise to offer automated analysis across experimental animals, pets, livestock, and patients. With a team of top neuroscientists and extensive global collaborations, we provide versatile solutions that push the boundaries of biomedical research.

Learn More
Expertise

Our team comprises leading neuroscientists, doctors, and postdoctoral fellows from the City University of Hong Kong. Their deep knowledge in neuroscience drives the innovation behind our platform.

Versatility

With over ten automated behavioral analysis modules, our platform caters to a wide range of applications, including experimental animals, pets, livestock, and patients, ensuring comprehensive coverage in brain disease research.

Technology

At the heart of our platform is Animism™, a multimodal AI large model that integrates cutting-edge machine learning algorithms with biomedical data to offer unparalleled behavioral analysis.

Collaboration

We work closely with global customers and medical institutions, creating a network of partnerships that accelerates research and development in the biomedical field.

Our Founders

Driving innovation and excellence, our team leaders bring unparalleled expertise and visionary leadership to TKN Biotech’s mission of transforming  the future of neurobehavioral health with cutting-edge AI technology.

John REN
Founder, CEO

john.ren@tknai.com

EE Master and NS PhD of CityU HK
Behavioral Monitoring Engineer of THU and PolyUHK

Shirley HE
Co-Founder, CSO

shirley.he@tknai.com

Biology Bachelor of HIT and BMS PhD of CityU HK
Research Associate of CityU HK

Jojen XIAO
Co-Founder, CTO

jojen.xiao@tknai.com

EE Master of CUHK and NS PhD of CityU HK
AI Algorithm Engineer of BGI and Sensetime

Our Partners